Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Net Cash Flow (2020 - 2026)

Biomea Fusion (BMEA) posted Net Cash Flow of -$11.1 million for Q1 2026, down 221.25% sequentially from $9.2 million in Q4 2025, and up 50.39% YoY from -$7.4 million in Q1 2025.

Biomea Fusion (BMEA) Net Cash Flow (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Net Cash Flow for 7 years, with the latest figure at -$11.1 million in Q1 2026.

  • Quarterly Net Cash Flow rose 50.39% year-over-year to -$11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (up 108.1% YoY) and the FY2025 annual result came in at -$2.5 million, up 97.92% from the prior year.
  • Net Cash Flow eased to -$11.1 million in Q1 2026 per BMEA's latest filing, from $9.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $136.6 million in Q2 2023 and troughed at -$31.9 million in Q1 2024.
  • A 5-year average of -$5.9 million and a median of -$20.4 million in 2022 frame the typical range for Net Cash Flow.
  • The widest YoY moves for Net Cash Flow: up 1866.33% in 2023, down 344.29% in 2023.
  • Over 5 years, Net Cash Flow stood at -$20.4 million in 2022, then declined by 8.87% to -$22.2 million in 2023, then tumbled by 33.52% to -$29.7 million in 2024, then surged by 130.9% to $9.2 million in 2025, then sank by 221.25% to -$11.1 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$11.1 million, $9.2 million, and -$9.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -183.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 407.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -496,000.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2.83 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.14 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 225.59 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - -10.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.03 Mn
Jun 30, 2026 -10.03 Mn
Mar 31, 2026 -11.12 Mn
Mar 31, 2026 -11.12 Mn
Dec 31, 2025 9.17 Mn
Dec 31, 2025 9.17 Mn
Sep 30, 2025 -9.58 Mn
Sep 30, 2025 -9.58 Mn
Jun 30, 2025 20.36 Mn
Jun 30, 2025 20.36 Mn
Mar 31, 2025 -22.42 Mn
Mar 31, 2025 -22.42 Mn
Dec 31, 2024 -29.67 Mn
Dec 31, 2024 -29.67 Mn
Sep 30, 2024 -25.33 Mn
Sep 30, 2024 -25.33 Mn
Jun 30, 2024 -31.63 Mn
Jun 30, 2024 -31.63 Mn
Mar 31, 2024 -31.95 Mn
Mar 31, 2024 -31.95 Mn